The board of directors of Sun Pharmaceutical Industries has approved share buyback amid broad market sell-off. The board in today’s meeting, approved equity share buyback of Rs 1,700 crore at a maximum price of Rs 425 apiece, which represents nearly 15 per cent premium from Monday’s closing